According to a company report, Apple’s wearables, home, and accessory business, which includes the Apple Watch, made $8.28 billion in revenue in Q3 2023. Apple has continually refuted Masimo’s claims as a ploy to commercialize its own FDA-cleared health-tracking smartwatch, which allegedly has internal and external similarities to the Apple Watch.

Back in May, a California federal jury trial ended with a mistrial, with six voting that Apple did not infringe on trade secrets, while one took Masimo’s side.

Apple is also currently involved in a legal dispute with AliveCor. In late 2022, the ITC ruled that it stole AliveCor patents to create wearable EKG technology for its Apple Watches. Biden also did not overturn that ruling, but the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office ruled AliveCor’s patents were invalid, preventing the ITC ruling from affecting sales.

Wedbush Securities analyst Dan Ives told the Associated Press in December that the disputes with Masimo and AliveCor indicate that Apple may eventually have to enter into licensing deals or acquire startups specializing in the field to integrate these features with its watches.

Back to HCB News

Business Affairs Homepage